STOCK TITAN

CNBXD Stock Price, News & Analysis

CNBXD OTC

Company Description

CNBXD (OTC: CNBXD) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $5.9M.

CNBXD stock has gained 58.3% over the past year.

This page provides a comprehensive overview of CNBXD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
+58.33%
Performance 1 year

CNBXD (CNBXD) stock. Over the past 12 months, the stock has gained 58.3%. At a market capitalization of $5.9M, CNBXD is classified as a micro-cap stock with approximately 1.2M shares outstanding.

Latest News

CNBXD has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all CNBXD news →

SEC Filings

No SEC filings available for CNBXD.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CNBXD Company Profile & Sector Positioning

CNBXD (CNBXD) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing CNBXD often look at related companies in the same sector, including Polyrizon Ltd (PLRZ), 60 degrees pharmaceuticals, Inc. (SXTP), Titan Pharmaceut (TTNP), Clearmind Medici (CMND), and Artelo Biosciences Inc (ARTL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNBXD's relative position within its industry.

Frequently Asked Questions

What is the market cap of CNBXD (CNBXD)?

The market cap of CNBXD (CNBXD) is approximately 5.9M. Learn more about what market capitalization means .